Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Gains from Sales and Divestitures (2018 - 2025)

Historic Gains from Sales and Divestitures for Mesa Laboratories (MLAB) over the last 8 years, with Q4 2025 value amounting to $65.0.

  • Mesa Laboratories' Gains from Sales and Divestitures rose 8055.56% to $65.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $65.0, marking a year-over-year increase of 8055.56%. This contributed to the annual value of $37000.0 for FY2025, which is 3214.29% up from last year.
  • Latest data reveals that Mesa Laboratories reported Gains from Sales and Divestitures of $65.0 as of Q4 2025, which was up 8055.56% from $62.0 recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' Gains from Sales and Divestitures registered a high of $37000.0 during Q1 2025, and its lowest value of $20.0 during Q2 2023.
  • Over the past 5 years, Mesa Laboratories' median Gains from Sales and Divestitures value was $65.0 (recorded in 2025), while the average stood at $11387.9.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first surged by 4632857.14% in 2022, then plummeted by 9984.62% in 2023.
  • Quarter analysis of 5 years shows Mesa Laboratories' Gains from Sales and Divestitures stood at $28.0 in 2021, then skyrocketed by 46328.57% to $13000.0 in 2022, then tumbled by 99.79% to $27.0 in 2023, then soared by 33.33% to $36.0 in 2024, then skyrocketed by 80.56% to $65.0 in 2025.
  • Its Gains from Sales and Divestitures stands at $65.0 for Q4 2025, versus $62.0 for Q3 2025 and $53.0 for Q2 2025.